HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dongfeng Chen Selected Research

N'- ((3Z)- 1- (1- hexyl)- 2- oxo- 1,2- dihydro- 3H- indol- 3- ylidene)benzohydrazide

1/2019MDA19, a novel CB2 agonist, inhibits hepatocellular carcinoma partly through inactivation of AKT signaling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dongfeng Chen Research Topics

Disease

20Neoplasms (Cancer)
03/2022 - 11/2009
10Parkinson Disease (Parkinson's Disease)
01/2022 - 01/2019
9Inflammation (Inflammations)
12/2021 - 06/2009
8Non-alcoholic Fatty Liver Disease
07/2021 - 01/2013
4Hepatocellular Carcinoma (Hepatoma)
11/2021 - 01/2019
4Stomach Neoplasms (Stomach Cancer)
03/2021 - 11/2009
4Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2021 - 12/2017
4Sepsis (Septicemia)
12/2019 - 06/2016
3Cognitive Dysfunction
01/2021 - 01/2018
3Ischemic Stroke
01/2021 - 03/2019
3Pulmonary Fibrosis (Fibrosing Alveolitis)
07/2020 - 06/2009
3Diarrhea
01/2020 - 10/2016
3Carcinoma (Carcinomatosis)
01/2018 - 07/2013
3Glioma (Gliomas)
03/2014 - 01/2013
2Arthritis (Polyarthritis)
04/2022 - 09/2020
2Crohn Disease (Crohn's Disease)
01/2022 - 12/2017
2Ulcerative Colitis
01/2022 - 01/2019
2Hypersensitivity (Allergy)
12/2021 - 12/2019
2Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
12/2021 - 01/2020
2Osteosarcoma (Osteogenic Sarcoma)
07/2021 - 05/2012
2Carcinogenesis
07/2021 - 03/2021
2Colitis
01/2021 - 01/2019
2Autistic Disorder (Autism)
01/2021 - 01/2021
2Body Weight (Weight, Body)
01/2021 - 01/2019
2Gouty Arthritis
09/2020 - 01/2020
2Multiple Organ Failure (MODS)
12/2019 - 10/2016
2Acute Lung Injury
08/2018 - 06/2009
2Glaucoma
02/2018 - 12/2005
2Cardiovascular Diseases (Cardiovascular Disease)
01/2017 - 02/2014
2Fatty Liver
02/2014 - 01/2013
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
05/2022
1Joint Diseases (Joint Disease)
04/2022
1Hematologic Neoplasms (Hematological Malignancy)
03/2022
1Osteoarthritis
01/2022
1Pancreatitis
01/2022
1Dyskinesias (Dyskinesia)
01/2022
1Primary Graft Dysfunction
12/2021
1Liver Neoplasms (Liver Cancer)
11/2021
1Insulin Resistance
07/2021
1Metabolic Diseases (Metabolic Disease)
07/2021
1Bone Fractures (Bone Fracture)
05/2021
1Femoral Fractures (Femoral Fracture)
05/2021

Drug/Important Bio-Agent (IBA)

9MicroRNAs (MicroRNA)IBA
01/2021 - 01/2017
6Proteins (Proteins, Gene)FDA Link
12/2021 - 11/2014
6LipopolysaccharidesIBA
06/2020 - 06/2009
5Pharmaceutical PreparationsIBA
01/2022 - 11/2009
4Biomarkers (Surrogate Marker)IBA
12/2021 - 02/2014
4Messenger RNA (mRNA)IBA
01/2021 - 01/2019
4HMGB1 Protein (HMG1)IBA
12/2019 - 06/2016
3Therapeutic UsesIBA
03/2022 - 10/2013
3Transcription Factors (Transcription Factor)IBA
08/2018 - 01/2013
2Sorting NexinsIBA
01/2022 - 01/2021
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 07/2021
2Protein Kinases (Protein Kinase)IBA
11/2021 - 03/2019
2LipidsIBA
07/2021 - 03/2016
2CateninsIBA
03/2021 - 01/2021
2Dextran SulfateIBA
01/2021 - 01/2019
2Oxidopamine (6 Hydroxydopamine)IBA
10/2020 - 01/2019
2InflammasomesIBA
09/2020 - 01/2020
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
06/2020 - 03/2018
2Bile Acids and Salts (Bile Acids)IBA
01/2020 - 01/2018
2paeonolIBA
12/2019 - 08/2018
2tetra-4-amidinophenoxypropane (TAPP)IBA
10/2019 - 12/2018
2Proton Pump InhibitorsIBA
10/2018 - 09/2014
2Small Interfering RNA (siRNA)IBA
05/2017 - 01/2016
2Testosterone (Sustanon)FDA Link
09/2015 - 10/2013
2Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
03/2014 - 01/2013
1Chimeric Antigen ReceptorsIBA
03/2022
1Levodopa (L Dopa)FDA LinkGeneric
01/2022
1A-factor (Streptomyces)IBA
01/2022
1Phytic Acid (Inositol Hexaphosphate)IBA
01/2022
1ImmunosorbentsIBA
01/2022
1Dopamine Agonists (Dopamine Agonist)IBA
01/2022
1Peptide Hydrolases (Proteases)FDA Link
01/2022
1maclurinIBA
01/2022
1EnzymesIBA
01/2022
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2022
1ElementsIBA
01/2022
1Butyric Acid (Butanoic Acid)IBA
12/2021
1Interleukin-1 Receptor-Associated KinasesIBA
12/2021
1Prostaglandins DIBA
12/2021
1CarbohydratesIBA
11/2021
1AntigensIBA
11/2021
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
11/2021
1Dopamine (Intropin)FDA LinkGeneric
09/2021
1plastrum testudinisIBA
09/2021
1Environmental Pollutants (Pollutants, Environmental)IBA
07/2021
1cyasteroneIBA
05/2021
1sharpinIBA
03/2021

Therapy/Procedure

17Therapeutics
01/2022 - 06/2002
6Fecal Microbiota Transplantation
01/2021 - 10/2016
2Electroacupuncture
05/2022 - 01/2021
2Molecular Targeted Therapy
01/2022 - 01/2021
2Moxibustion
01/2021 - 01/2019
1Acupuncture Points (Acupuncture Point)
05/2022
1Chinese Traditional Medicine (Traditional Chinese Medicine)
04/2022
1Duration of Therapy
01/2022
1Immunotherapy
01/2022
1Cell Transplantation
01/2022
1Heart Transplantation (Grafting, Heart)
12/2021